R&D Strength

MORE +
scroll down

Last year, China’s trade deficit in vascular stents was significant.


There are a total of 53 companies in China engaged in the import of vascular stents, including 17 foreign-invested enterprises with an import value of US$248 million

The new method can control stem cell differentiation on demand.


Stem cells are highly versatile, and scientists have long been puzzled about which organs or tissues they will ultimately become. According to a report by the American Physical Society’s website on August 28

Biopharmaceutical planning is coming your way.


With news that the 12th Five-Year Plan for the pharmaceutical industry is about to be released, the biopharmaceutical sector has shown exceptionally strong performance

Bacterial antibiotic resistance has long had genetic origins.


Antibiotics have been used as medications for less than a century, yet today, superbugs with antibiotic resistance are causing headaches for the medical community.

China’s biopharmaceutical market is set to reach 800 billion yuan, with strong demand for new vaccines.


Fu Mingzhong, Executive President of the China Pharmaceutical Commerce Association, recently predicted at the 69th China Pharmaceutical Fair that the biopharmaceutical
< 1...6789 > proceed page